ClickCease

A shared mission

When it comes to using AI for pharma discovery, Recursion is the TechBio partner of choice. We collaborate with leading biopharmaceutical and technology companies to broadly explore diverse disease domains and rapidly identify novel therapeutic candidates.

Interested in partnering with Recursion, a top AI drug discovery company? Connect with us at partner@recursion.com.

The Bayer - Recursion Oncology Collaboration

The Neuroscience and GI Oncology Collaboration with Roche and Genetech

One of The Most Powerful Supercomputers in Pharma

Therapeutic partners

Technology, data, and capability partners

The goal of every partnership is to create therapeutics. The approach takes multiple forms:

Strategic
collaboration

In order to achieve our mission as an AI drug discovery company, we partner with leading biotechnology companies, pharmaceutical companies and academic research institutions to identify novel therapeutics and unlock biological insights using our discovery technology and AI for pharma. Our partnering efforts take two primary forms: discovery platform partnerships and asset development partnerships.

Asset development partnership

In addition to NCEs, the Recursion Map may discover new uses for known chemical entities owned or controlled by third parties. In such circumstances, we may in-license rights to these assets to advance these programs internally.

Discovery platform partnerships

We have collaborated with third parties to broadly explore diverse disease domains (e.g., fibrosis, neuroscience, and oncology). Collaborations leverage our partner's deep domain expertise and Recursion's unique capability to map and navigate complex biology to identify and rapidly advance potential therapeutics.

Interested in partnering?

Contact us
© 2026 Recursion. All rights reserved.